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Abstract
Background—We evaluated the risk of incident heart failure (HF) associated with various 
categories of ventricular conduction defects (VCD) and examined the impact of QRS duration on 
the risk of HF.
Methods and Results—This analysis included 14,478 participants from the Atherosclerosis 
Risk in Communities (ARIC) study who were free of HF at baseline. VCDs (n=377) were 
categorized into right and left bundle branch blocks (RBBB and LBBB, respectively), bifascicular 
BBB (RBBB with fascicular block), indetermined type VCD (IVCD), and pooled-VCD group 
excluding lone RBBB. During an average of 18 years follow-up, 1,772 participants were 
hospitalized for incident HF. Compared to No-VCD, LBBB and pooled-VCD were strongly 
associated with increased risk of incident HF (multivariable hazard ratio 2.87 and 2.29, 
respectively). Compared to No-VCD with QRS duration <100 ms, HF risk was 1.17-fold for the 
No-VCD group with QRS duration 100–119 ms, 1.97-fold for pooled-VCD group with QRS 
duration 120–139 ms and 3.25-fold with QRS duration ≥140 ms. HF risk for pooled VCD group 
remained significant (1.74-fold for QRS duration 120–139 ms and 2.81-fold for QRS duration 140 
ms or longer) in the subgroup free from cardiovascular disease at baseline. Lone RBBB was not 
associated with incident HF.
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Conclusions—VCDs except for isolated RBBB are strong predictors of incident HF, and HF 
risk is further increased as the QRS duration is prolonged above 140 ms.
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INTRODUCTION
Heart failure (HF) is known to be more common among patients with bundle branch blocks 
(BBB) than those with normal ventricular conduction.
1
 Previous reports have shown that left 
BBB (LBBB),
2–5 but not right BBB (RBBB),
5–9 is associated with excess risk of incident 
HF. The Framingham study in men and women with BBB found that the risk of incident HF 
increased progressively with increasing QRS duration.
2
 The objective of the present study 
was to compare the prognostic significance of different patterns of ventricular conduction 
defects (VCD) as predictors of incident. VCDs considered include the main stem BBB 
according to traditional definitions and indetermined type VCD (IVCD).
METHODS
Study population and design
The study population was selected from the participants in the Atherosclerosis Risk in 
Communities (ARIC) Study, a population-based multicenter prospective study designed to 
investigate the natural history and cause of atherosclerotic and cardiovascular disease. 
Participants (n=15,792 men and women aged 45–64 years) were recruited from 4 US 
communities in Forsyth County, North Carolina; Jackson, Mississippi; suburbs of 
Minneapolis, Minnesota; and Washington County, Maryland. Eligible participants were 
interviewed at home and then invited to a baseline clinical examination between 1987 and 
1989. Participants attended 3 additional clinical examinations at 3-year intervals and 
received a follow-up phone interview yearly. Details of the ARIC Study design, protocol 
sampling procedures, and selection and exclusion criteria were published elsewhere.
11
 The 
study was approved by each study site’s institutional review board. All participants provided 
written informed consent. A total 1,314 participants were excluded from analyses: 405 
without an electrocardiogram (ECG) or completed clinical data for heart failure, 126 with 
inadequate quality ECG, or an external pacemaker or Wolff-Parkinson-White pattern, 44 
with race other than black or white, and 739 with prevalent HF at baseline. After all 
exclusions, 14,478 participants, of whom 377 had VCD, remained and were included in this 
analysis.
Outcome ascertainment
Incident HF occurred from baseline through December 31, 2006 was considered in the 
present investigation. The follow-up period was up to 20 years (mean 18 years). Incident HF 
was defined by International Classification of Disease (ICD) codes as the first occurrence of 
either a hospitalization with a HF hospital discharge diagnosis code (ICD-9th Revision, 
Clinical Modification, code 428), or a death certificate with any listing of a 428 ICD-9 code 
or code I50 ICD-10 code, without a previous record of hospitalization as code 428). Detailed 
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definitions for incident HF classification were published previously.
12–13 Cardiovascular 
disease (CVD) at baseline was defined as presence of ECG myocardial infarction (MI) 
according to the Minnesota Code (MC)
14
 or the NOVACODE
15
 criteria, or a self-reported 
history of a clinical diagnosis of MI, angina pectoris, coronary artery bypass surgery, 
coronary angioplasty, HF, or stroke at the time entered the ARIC study.
16
ECG methods
Identical electrocardiographs (MAC PC, Marquette Electronics Inc., Milwaukee, Wisconsin) 
were used at all clinic sites, and resting, 10-second standard simultaneous 12-lead ECGs 
were recorded in all participants using strictly standardized procedures. All ECGs were 
processed in a central ECG laboratory (initially at Dalhousie University, Halifax, NS, 
Canada and later at the EPICARE Center, Wake Forest School of Medicine, Winston-Salem, 
NC), where all ECGs were visually inspected for technical errors and inadequate quality 
using an interactive computer graphics terminal. The ECGs were first processed by the 
Dalhousie ECG program and were reprocessed for the present study using the 2001 version 
of the GE Marquette 12-SL program (GE, Milwaukee, Wisconsin). VCD were classified 
according to the MC criteria,
13
 for complete LBBB (MC-7.1), complete RBBB (MC-7.2, 
QRS axis >−45 degree), indetermined type VCD (IVCD, MC-7.4), combination of RBBB 
and left anterior fascicular block (LAFB) (MC-7.8, RBBB and QRS axis between −45 and 
−120 degree), and combination of RBBB and left posterior fascicular block (LPFB) 
(MC-7.8, RBBB and QRS axis between 91 and 180 degree).
14,17–18 Combined LBBB, 
IVCD, and bifascicular block was labeled pooled VCD group.
Statistical methods
Frequency distributions of ECG measurements were inspected to identify anomalies and 
outliers. Descriptive statistics were used to determine mean values, standard deviations, and 
percentile distributions for continuous variables, and frequencies and percentages for 
categorical variables. Cox's Proportional Hazards (CPH) analysis was used to assess the 
associations of BBB with the risk of HF in incremental models as follows: model-1, 
unadjusted; model-2 adjusted for age, sex, and race; and model-3 adjusted for age, sex, race, 
regional center, body mass index, systolic blood pressure, smoking status, education level, 
hypertension, diabetes mellitus, history of CVD status, ratio of total cholesterol/HDL, blood 
glucose, and serum creatinine at baseline). The effect of QRS duration on the risk of HF was 
compared at two dichotomized levels as suggested by a recent recommendation:
19–20 at 
140ms and at 150 ms as recommended also in the report of the American College of 
Cardiology Foundation/ American Heart Association and Heart Rhythm society for Cardiac 
Resynchronization Therapy.
21
 All analyses were performed with SAS version 9.3 (SAS 
Institute Inc., Cary, North Carolina).
RESULTS
Study group characteristics
The mean age at baseline was 54 years (SD 5.8), 54.6% were women, 73.4% white, and 
26.3% African American. Of the study group, 32.7% had hypertension, 11.1% diabetes, and 
5.2% had a history of CVD or ECG evidence of MI. Details of demographic, clinical, and 
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ECG characteristics of the study population stratified by VCD status are summarized in 
Table 1. As shown, most of the demographic, clinical characteristics, and ECG 
measurements were different between the two groups with the VCD group having more 
prevalence of CVD risk factors.
The patterns of bundle branch blocks and incident heart failure
VCD was present in 2.6% (377/14,478) including 159 RBBB and 75 LBBB, and 218 in the 
pooled-VCD group. During an average of 18 years follow-up, 1,772 HF events occurred. 
The event rate was 23.7 per 1000 person-years for the participant with pooled-VCD (where 
LBBB, IVCD and RBBB combined with LAFB/LPFB were all strong predictors of incident 
HF with HRs ranging from 1.75 for IVCD to 2.87 for LBBB in Table 2), 14.7 for the 
participants with RBBB, and 7.2 per 1000 person-years among those with No-BBB. 
Compared to the No-VCD group, LBBB was a strong predictor for incident HF (HR 2.87, 
95% CI 1.94–4.25, P<0.001) in multivariable adjustment models. Figure 1 shows the 
cumulative incidence of HF by VCD category.
The QRS prolongation and incident heart failure
Using the No-VCD participants with QRS duration <100 ms as the reference group, the 
group with QRS duration 100–119 ms had a 1.17-fold (p<0.01) risk of incident HF (Table 
3). When stratified by the level of QRS duration 140 ms as a cut point, the risk of incident 
HF in the pooled-VCD group was 1.97-fold (p<0.001) for QRS duration range 120–139 ms 
and 3.25-fold (p<0.001) for QRS duration ≥140 ms. Survival free of incident heart failure 
graphs for HF by VCD category and QRS duration by 140ms cutoff are shown in Figure 2. 
The results were essentially the same when QRS duration 150ms was used as the cutoff 
point (not shown). Excluding participants CVD at baseline, a significant HF risk was 
retained in the pooled-VCD group with 1.74-fold (HR 1.74, 95% CI 1.16–2.62, P<0.01) 
increased risk in the fully adjusted model for QRS duration 120–139 ms and 2.81-fold (HR 
2.81, 95% CI 1.80–4.39, P<0.001) increased risk and for QRS duration >140 ms (Table 4).
DISCUSSION
The present study is a comprehensive analysis to evaluate the risk of incident HF in 
subgroups stratified by specific BBB category, QRS duration, sex, race, and age. The key 
findings in the fully-adjusted risk model: 1) Compared to No-VCD with QRS duration 
<120ms, LBBB, IVCD and RBBB combined with LAFB or LPFB (bifascicular block) were 
all strong predictors of incident HF; 2) Lone RBBB was not a significant predictor of 
incident HF; 3) Using No-VCD with QRS duration <100 ms as the reference group, incident 
HF risk was nearly 2-fold for pooled-VCD group with QRS duration 120–139 ms and over 
3-fold for QRS duration ≥140 ms; 4) Excluding participants with CVD at baseline, a 
significant HF risk was retained in the pooled-VCD group.
Possible mechanisms accounting for increased HF risk in bundle branch blocks
On body surface ECG, QRS complex represents ventricular electrical depolarization that 
initiates ventricular contraction, whereas the T wave represents ventricular electrical 
repolarization that is associated with ventricular relaxation. Delayed left ventricular 
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excitation and contraction in VCD may lead into dyssynchrony of ventricular contraction, 
and also into delayed left ventricular repolarization and relaxation. Reduced cardiac function 
in VCD reflects a possible cause-and-effect relation between VCD and HF, and it has 
become an important consideration in resynchronizing therapy for HF patients.
20–26 In 
normal ventricular depolarization and repolarization, the direction of repolarization in the 
left lateral wall is predominantly reversed with respect to the direction of depolarization. In 
BBB particularly with more pronounced QRS prolongation and delayed excitation times, the 
repolarization sequence becomes predominantly concordant with respect to the direction of 
depolarization. Prolonged left ventricular depolarization prolongs and alters the spatial 
direction of the repolarization sequence which in turn is thought to be associated with 
impaired diastolic function.
26
 Our results demonstrated that VCD with more pronounced 
prolonged QRS (≥140 ms) was associated with a substantial additional increase of the risk 
for HF.
Our results in relation to work done by other investigators
LBBB has been associated with excess risk of incident HF in many studies,
2–5 but not 
RBBB.
5–7 In a report from the Heart Outcomes Prevention Evaluation (HOPE) trial,
3 
baseline LBBB was an independent predictor of HF, sudden death, CVD death, and all cause 
death, but baseline RBBB was not associated with increased CVD risk. Zhang
5
 et al. 
evaluated the risk of incident HF for BBBs with over 14 years of follow-up for 65,975 
participants in the Women’s Health Initiative study, and found that LBBB, IVCD, and 
RBBB combined with LAFB were strong predictors of incident HF in multivariable adjusted 
risk models, but RBBB was not a significant predictor. The study also showed that LBBB in 
women with QRS duration ≥140 ms had a much greater predictive value for incident HF 
than LBBB with QRS duration 120–139 ms. In the predominantly white Framingham 
population, the impact of QRS duration on HF risk was evaluated among subject with and 
without BBB, with baseline log-QRS duration modeled as a continuous variable.
2
 the 
incidence of HF increased 1.2-fold for 1 SD increase in QRS duration (HR 1.23; 95% CI 
1.08–1.38; P<0.001) in multivariable model. And the highest rates of HF were for LBBB 
(HR 4.45, P=0.0001) and for IVCD (HR 2.18, P=0.02), but the risk was not significantly 
increased for RBBB. Our results in BBB categories are consistent with the above results 
from the Framingham study. MESA study evaluated in their multiethnic population with 
normal ventricular conduction the impact of QRS duration >100 ms on incident HF.
10.
 In 
multivariable model adjusted for age, sex and race, the risk for incident HF was increased 
over 2-fold (HR 2.10, 95% CI 1.29–3.42, p<0.01) during the mean follow-up 7.1 years. 
Aro
27
 et al. in their study population of 2,049 men found that a QRS duration threshold of 
110 ms was an optimal cut point to define a prolonged QRS duration as a risk factor. The 
findings in that study and those in MESA study are consistent with those in our study group 
without VCD.
Clinical implications
VCDs are manifestations of a gradually evolving generalized degenerative process involving 
not only bundle branches but also structural changes in working myocardium. This suggests 
that early primary prevention of CHD can be expected to have a more significant overall 
impact. More prolonged QRS duration may indicate a more pronounced risk of HF before 
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and also after VCD develops. Once clinical signs of HF develop, secondary prevention 
efforts involve management of HF including consideration for resynchronization therapy.
Study limitations
Similar to other observational studies, residual confounding remains a possibility despite 
adjusting for several potential confounders. Also, our results may not be generalizable to 
race/ethnicities other than whites and blacks. Finally, new-onset HF was defined by 
hospitalizations for HF or death certificate identifying HF as the cause of death without prior 
hospitalization. This means that our results pertain mainly to the risk of the HF requiring 
hospitalization. Despite these limitations, this is the first comprehensive analysis of the 
impact of QRS morphology (i.e. VCD patterns) and duration (i.e. prolongation) on the risk 
of HF. Further, all data used in the analysis including ECG data were carefully ascertained 
and/or read at central core labs.
Conclusion
VCDs except for isolated RBBB are strong predictors of incident HF, and HF risk is further 
increased as the QRS duration is prolonged above 140ms.
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• Heart failure (HF) risk was assessed for ventricular conduction defects (VCD).
• VCDs except for isolated RBBB were strong predictors of new-onset HF.
• HF risk was further increased as QRS duration was prolonged above 140 ms.
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Survival free of incident heart failure during an average 18 years follow-up by ventricular 
conduction defect category
No-Ventricular Conduction Defect= QRS duration <120 ms; Bifascicular Block= Right 
bundle branch block with left anterior fascicular block, or with left posterior fascicular 
block.
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Survival free of incident heart failure during an average 18 years follow-up by QRS duration 
and ventricular conduction defect category
No-VCD= No ventricular conduction defect;
Lone RBBB= Isolated right bundle branch block;
Pooled-VCD Group= combined left bundle branch block, indetermined type VCD, and 
bifascicular block (right bundle branch block with left anterior fascicular block, or with left 
posterior fascicular block).
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Table 1
Baseline characteristic of study participants
Total N=14,478









Age (years) 54 (5.7) 57 (5.4) <.001
Body mass index (kg/m2) 28 (5.3) 28 (4.8) 0.029
Systolic blood pressure (mmHg) 121 (17.7) 124 (20.9) <.001
Women 7780 (55.2%) 121 (32.1%) <.001
Race/ethnicity 0.527
  White 10377 (73.4%) 281 (74.5%)
  African-American 3724 (26.3%) 96 (25.5%)
Education ≤ high school 7799 (55.4%) 233 (61.8%) 0.002
Current smoker 3649 (25.9%) 104 (27.6%) 0.032
History of CVD 691 (4.9%) 66 (17.5%) <.001
Diabetes 1536 (11.0%) 56 (14.9%) 0.016
Hypertension 4583 (32.5%) 151 (40.1%) 0.002
Antihypertensives 3810 (27.0%) 145 (38.5%) <.001
Hypertension/Antihypertensives 5129 (36.4%) 180 (47.7%) <.001
Hypertensives with ECG-LVH 208 (4.5%) - <.001
ECG-LVH 261 (1.8%) - <.001
ECG-Myocardial infarction 469 (3.3%) 51 (13.5%) <.001
Ratio of total cholesterol/HDL 4.6 (1.7) 5.1 (1.7) <.001
Blood glucose 108 (39.4) 110 (35.2) 0.274
Serum creatinine 1.1 (0.4) 1.2 (0.9) <.001
Heart rate (/min) 66 (10.2) 64 (10.5) <.001
QRS duration (ms) 91 (9.5) 136 (14.7) <.001
VCD = ventricular conduction defect.
*
P values between the groups of No-VCD and VCD.
CVD= cardiovascular disease.
ECG-LVH = ECG-Left Ventricle Hypertrophy by Cornell voltage criteria
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